Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

Allogeneic hematopoietic SCT (HSCT) increases the risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen ... B core antigen (anti-HBc)-positive recipients are not well ...

Testing for hepatitis B surface antibodies was positive. The blood globulin level was normal; other laboratory test results are shown in Table 1. Abdominal ultrasonography reportedly showed a ...

He tested positive for hepatitis B surface antigen (HBsAg ... In general, patients who are HbeAg positive and HBe antibody (HBeAb) negative are considered to have ongoing HBV replication.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

They are considered protected if they have a hepatitis B surface antigen antibody (anti-HBs) titer of ≥10 mIU/mL after completing a full vaccination series. This study compared the effectiveness ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis ... people who are either positive for the HBV surface antigen (HBsAg) or HBV core antibody (anti-HBc).

Hepatitis B surface antigen vaccine (recombinant ... Recombivax HB has been shown to elicit antibodies to hepatitis B virus as measured by ELISA. Antibody concentrations ≥10mIU/mL against ...